These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Immunophilin ligands: from immunosuppressants to neuroprotective drugs]. Tanaka K; Ogawa N Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):71-4. PubMed ID: 15164613 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection. Lieberman JA CNS Spectr; 2007 Oct; 12(10 Suppl 18):4-6. PubMed ID: 17934388 [No Abstract] [Full Text] [Related]
16. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis. Mirowska-Guzel D Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835 [TBL] [Abstract][Full Text] [Related]
17. Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system. Gardiner J; Barton D; Overall R; Marc J Neuroscientist; 2009 Feb; 15(1):47-61. PubMed ID: 19218230 [TBL] [Abstract][Full Text] [Related]
18. Medical marijuana: emerging applications for the management of neurologic disorders. Carter GT; Ugalde V Phys Med Rehabil Clin N Am; 2004 Nov; 15(4):943-54, ix. PubMed ID: 15458761 [TBL] [Abstract][Full Text] [Related]
19. Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology. Liberini P; Cuello AC Rev Neurosci; 1994; 5(2):89-104. PubMed ID: 7827710 [No Abstract] [Full Text] [Related]
20. Molecular and cell-based approaches for neuroprotection in glaucoma. Lebrun-Julien F; Di Polo A Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]